DRWF Research: Dr Tara Lee awarded the DRWF Sutherland-Earl Clinical Fellowship
Published on 31 January 2022
Three-year study will look at use of continuous glucose monitoring technology by pregnant women with type 1 diabetes.
DRWF is delighted to announce the latest recipient of the Sutherland-Earl Fellowship for a study on continuous glucose monitoring technology by pregnant women with type 1 diabetes.
The latest award has been made to Dr Tara Lee, of the University of East Anglia for the DILIGENT (Use of Diabetes technology on birthweight, Labour, Inpatient and postpartum Glycaemia of pregnant womEN with Type 1 diabetes) study.
The Sutherland-Earl Clinical Fellowship is awarded every other year. Applications are invited from medically qualified doctors (MBChB or equivalent) working towards a higher degree, ie MD or PhD.
DRWF Sutherland-Earl Clinical Research Fellowships cover a period of up to 3 years, in a recognised institution or department within the United Kingdom.
The DRWF Sutherland-Earl Clinical Research Fellowship award to Dr Lee from 2021 is £237,007.
The lay summary for the study by Dr Lee said: “Despite increased use of continuous glucose monitoring (CGM) and insulin pumps, most pregnant women with type 1 diabetes struggle to manage their glucose levels in pregnancy.
“Many deliver large birthweight babies and experience additional challenges managing their diabetes during hospital admissions and after birth.
“My project will examine how the mother's glucose levels and insulin therapy relate to baby’s growth patterns and birthweight.
“It will also examine which diabetes technologies help pregnant women to achieve their glucose targets during hospital admissions and after birth.
“I will perform three studies: firstly, focusing on understanding baby’s growth patterns, secondly on examining mother’s glucose levels during hospital admissions, labour and delivery, and thirdly, during the six months after birth.
“My project addresses three top priority diabetes pregnancy research questions:
(1) use of diabetes technology to improve pregnancy care;
(2) women’s experiences and choices surrounding labour and delivery and
(3) postnatal care and support.”